| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.16e-10 | 17 | 105 | 6 | GO:0005132 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 4.97e-08 | 8 | 105 | 4 | GO:0004571 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.48e-07 | 10 | 105 | 4 | GO:0015924 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 9.42e-07 | 15 | 105 | 4 | GO:0004559 | |
| GeneOntologyMolecularFunction | mannosidase activity | 1.25e-06 | 16 | 105 | 4 | GO:0015923 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 3.00e-05 | 12 | 105 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.13e-04 | 103 | 105 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 3.14e-04 | 324 | 105 | 8 | GO:0005126 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D1 SLC10A4 TRPC5 PKD1L2 SLC8A3 SLC6A20 SCN8A TMEM38A SLC5A8 | 7.77e-04 | 465 | 105 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 8.18e-04 | 35 | 105 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 CACNA2D1 SLC10A4 TRPC5 PKD1L2 SLC4A3 SLC8A3 SLC6A20 SCN8A TMEM38A SLC5A8 TMC5 | 9.37e-04 | 793 | 105 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.64e-04 | 37 | 105 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 9.85e-04 | 144 | 105 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHA9 MAN1A1 PCDHA13 PCDHA12 PKD1L2 EDEM3 EFCAB9 HPGDS EDEM2 LRP1 EDEM1 | 1.95e-03 | 749 | 105 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | cytokine activity | 2.08e-03 | 250 | 105 | 6 | GO:0005125 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.10e-03 | 171 | 105 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 CACNA2D1 SLC10A4 TRPC5 PKD1L2 SLC4A3 SLC8A3 SLC6A20 SCN8A TMEM38A SLC5A8 | 2.14e-03 | 758 | 105 | 11 | GO:0015318 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 7.68e-10 | 21 | 105 | 6 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.88e-09 | 24 | 105 | 6 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 5.18e-09 | 28 | 105 | 6 | GO:0042501 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent glycoprotein ERAD pathway | 4.37e-08 | 8 | 105 | 4 | GO:0097466 | |
| GeneOntologyBiologicalProcess | protein deglycosylation involved in glycoprotein catabolic process | 4.37e-08 | 8 | 105 | 4 | GO:0035977 | |
| GeneOntologyBiologicalProcess | protein alpha-1,2-demannosylation | 4.37e-08 | 8 | 105 | 4 | GO:0036508 | |
| GeneOntologyBiologicalProcess | protein demannosylation | 4.37e-08 | 8 | 105 | 4 | GO:0036507 | |
| GeneOntologyBiologicalProcess | mannose trimming involved in glycoprotein ERAD pathway | 4.37e-08 | 8 | 105 | 4 | GO:1904382 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 6.81e-08 | 42 | 105 | 6 | GO:0002323 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 2.33e-07 | 124 | 105 | 8 | GO:0042100 | |
| GeneOntologyBiologicalProcess | response to glycoprotein | 3.04e-07 | 12 | 105 | 4 | GO:1904587 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 3.57e-07 | 55 | 105 | 6 | GO:0043330 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum mannose trimming | 5.11e-07 | 4 | 105 | 3 | GO:1904380 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 8.09e-07 | 63 | 105 | 6 | GO:0043331 | |
| GeneOntologyBiologicalProcess | negative regulation of ceramide biosynthetic process | 1.27e-06 | 5 | 105 | 3 | GO:1900060 | |
| GeneOntologyBiologicalProcess | mannoprotein catabolic process | 1.27e-06 | 5 | 105 | 3 | GO:0006058 | |
| GeneOntologyBiologicalProcess | mannoprotein metabolic process | 1.27e-06 | 5 | 105 | 3 | GO:0006056 | |
| GeneOntologyBiologicalProcess | protein deglycosylation | 1.84e-06 | 18 | 105 | 4 | GO:0006517 | |
| GeneOntologyBiologicalProcess | intracellular sphingolipid homeostasis | 2.54e-06 | 6 | 105 | 3 | GO:0090156 | |
| GeneOntologyBiologicalProcess | negative regulation of sphingolipid biosynthetic process | 4.42e-06 | 7 | 105 | 3 | GO:0090155 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 4.76e-06 | 85 | 105 | 6 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 5.09e-06 | 86 | 105 | 6 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 6.64e-06 | 90 | 105 | 6 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 7.54e-06 | 92 | 105 | 6 | GO:0034340 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 8.58e-06 | 143 | 105 | 7 | GO:1904892 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.07e-05 | 148 | 105 | 7 | GO:0002286 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 1.29e-05 | 101 | 105 | 6 | GO:0033138 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.73e-05 | 63 | 105 | 5 | GO:0050691 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 2.33e-05 | 112 | 105 | 6 | GO:0140888 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 2.57e-05 | 2 | 105 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 4.14e-05 | 124 | 105 | 6 | GO:0030101 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 4.33e-05 | 125 | 105 | 6 | GO:0046425 | |
| GeneOntologyBiologicalProcess | regulation of ceramide biosynthetic process | 4.48e-05 | 14 | 105 | 3 | GO:2000303 | |
| GeneOntologyBiologicalProcess | glycoprotein catabolic process | 5.55e-05 | 41 | 105 | 4 | GO:0006516 | |
| GeneOntologyBiologicalProcess | positive regulation of protein exit from endoplasmic reticulum | 5.58e-05 | 15 | 105 | 3 | GO:0070863 | |
| GeneOntologyBiologicalProcess | regulation of sphingolipid biosynthetic process | 6.84e-05 | 16 | 105 | 3 | GO:0090153 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 7.22e-05 | 137 | 105 | 6 | GO:0033135 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 7.64e-05 | 201 | 105 | 7 | GO:0030183 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 7.68e-05 | 3 | 105 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 9.68e-05 | 90 | 105 | 5 | GO:0050688 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 1.04e-04 | 365 | 105 | 9 | GO:0002263 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.20e-04 | 216 | 105 | 7 | GO:0097696 | |
| GeneOntologyBiologicalProcess | regulation of serine C-palmitoyltransferase activity | 1.53e-04 | 4 | 105 | 2 | GO:1904220 | |
| GeneOntologyBiologicalProcess | positive regulation of retrograde protein transport, ER to cytosol | 1.53e-04 | 4 | 105 | 2 | GO:1904154 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 1.84e-04 | 22 | 105 | 3 | GO:1902001 | |
| GeneOntologyBiologicalProcess | lipid transport | ANO4 SLC10A4 TRPC5 SPG11 VPS52 ABCD3 LRP1 IRS2 SLC5A8 VPS13B | 2.60e-04 | 506 | 105 | 10 | GO:0006869 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid metabolic process | 2.72e-04 | 25 | 105 | 3 | GO:1905038 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 2.94e-04 | 114 | 105 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 3.00e-04 | 251 | 105 | 7 | GO:0002285 | |
| GeneOntologyBiologicalProcess | regulation of protein exit from endoplasmic reticulum | 3.43e-04 | 27 | 105 | 3 | GO:0070861 | |
| GeneOntologyBiologicalProcess | B cell activation | 3.57e-04 | 341 | 105 | 8 | GO:0042113 | |
| GeneOntologyBiologicalProcess | ERAD pathway | 3.58e-04 | 119 | 105 | 5 | GO:0036503 | |
| GeneOntologyBiologicalProcess | defense response to virus | 3.64e-04 | 342 | 105 | 8 | GO:0051607 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | PDE1C PSEN2 TM9SF4 TRPC5 CP SLC4A3 SLC8A3 ORMDL1 ORMDL3 ORMDL2 TMEM38A LRP1 IRS2 | 4.53e-04 | 866 | 105 | 13 | GO:0055082 |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | 5.20e-04 | 361 | 105 | 8 | GO:0002366 | |
| GeneOntologyBiologicalProcess | gonadotrophin-releasing hormone neuronal migration to the hypothalamus | 5.30e-04 | 7 | 105 | 2 | GO:0021828 | |
| GeneOntologyBiologicalProcess | hypothalamic tangential migration using cell-axon interactions | 5.30e-04 | 7 | 105 | 2 | GO:0021856 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by transcytosis | 5.30e-04 | 7 | 105 | 2 | GO:0150093 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 5.31e-04 | 198 | 105 | 6 | GO:0007259 | |
| GeneOntologyBiologicalProcess | lipid localization | ANO4 SLC10A4 TRPC5 SPG11 VPS52 ABCD3 LRP1 IRS2 SLC5A8 VPS13B | 6.16e-04 | 565 | 105 | 10 | GO:0010876 |
| GeneOntologyBiologicalProcess | negative regulation of amide metabolic process | 6.84e-04 | 34 | 105 | 3 | GO:0034249 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CACNA2D1 MAN1A1 TRIM25 IFNA4 IFNA5 IFNA6 IFNA8 IFNA17 IFNA21 EDEM3 SLC8A3 EDEM2 TMEM38A LRP1 IRS2 EDEM1 | 6.87e-04 | 1272 | 105 | 16 | GO:1901698 |
| GeneOntologyBiologicalProcess | olfactory nerve development | 7.05e-04 | 8 | 105 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | motor behavior | 7.45e-04 | 35 | 105 | 3 | GO:0061744 | |
| GeneOntologyBiologicalProcess | response to endoplasmic reticulum stress | 7.86e-04 | 295 | 105 | 7 | GO:0034976 | |
| GeneOntologyBiologicalProcess | hypothalamus cell migration | 9.03e-04 | 9 | 105 | 2 | GO:0021855 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron differentiation | 9.03e-04 | 9 | 105 | 2 | GO:0021886 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron development | 9.03e-04 | 9 | 105 | 2 | GO:0021888 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 9.65e-04 | 148 | 105 | 5 | GO:0006986 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 9.80e-04 | 398 | 105 | 8 | GO:0046651 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 1.11e-03 | 406 | 105 | 8 | GO:0032943 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 1.12e-03 | 10 | 105 | 2 | GO:1990264 | |
| GeneOntologyBiologicalProcess | sphingomyelin biosynthetic process | 1.37e-03 | 11 | 105 | 2 | GO:0006686 | |
| GeneOntologyBiologicalProcess | cranial nerve formation | 1.37e-03 | 11 | 105 | 2 | GO:0021603 | |
| GeneOntologyBiologicalProcess | intracellular transport | TNPO1 KDELR2 MYO6 TM9SF4 WDR81 SPG11 WDPCP VPS52 DENND1B PPP6C TGFBRAP1 CLTC EDEM2 ABCD3 LRP1 EDEM1 VPS13B | 1.42e-03 | 1496 | 105 | 17 | GO:0046907 |
| GeneOntologyBiologicalProcess | cellular homeostasis | PDE1C PSEN2 TM9SF4 TRPC5 CP SLC4A3 SLC8A3 ORMDL1 ORMDL3 ORMDL2 TMEM38A LRP1 IRS2 | 1.43e-03 | 981 | 105 | 13 | GO:0019725 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.47e-03 | 96 | 105 | 4 | GO:0060113 | |
| GeneOntologyBiologicalProcess | response to virus | 1.49e-03 | 425 | 105 | 8 | GO:0009615 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO4 CACNA2D1 PSEN2 SLC10A4 TRPC5 CP SPG11 PKD1L2 SLC4A3 SLC8A3 SLC6A20 CLTC SCN8A TMEM38A SLC5A8 TMC5 | 1.55e-03 | 1374 | 105 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 1.61e-03 | 166 | 105 | 5 | GO:0035966 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA2D1 PSEN2 SLC10A4 TRPC5 CP SPG11 PKD1L2 SLC8A3 SLC6A20 CLTC SCN8A TMEM38A SLC5A8 | 1.69e-03 | 1000 | 105 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | behavior | PSEN2 MYO6 SLC10A4 SPG11 SLC8A3 ORMDL1 ORMDL3 HPGDS SCN8A CNTNAP4 ANKFN1 VPS13B | 1.91e-03 | 891 | 105 | 12 | GO:0007610 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.97e-03 | 104 | 105 | 4 | GO:0042490 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 1.98e-03 | 445 | 105 | 8 | GO:0070661 | |
| GeneOntologyCellularComponent | serine palmitoyltransferase complex | 6.97e-06 | 8 | 106 | 3 | GO:0017059 | |
| GeneOntologyCellularComponent | palmitoyltransferase complex | 2.03e-05 | 11 | 106 | 3 | GO:0002178 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 3.49e-05 | 13 | 106 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | endoplasmic reticulum quality control compartment | 8.18e-05 | 17 | 106 | 3 | GO:0044322 | |
| Domain | Interferon_alpha/beta/delta | 2.69e-10 | 17 | 102 | 6 | IPR000471 | |
| Domain | Interferon | 2.69e-10 | 17 | 102 | 6 | PF00143 | |
| Domain | IFabd | 2.69e-10 | 17 | 102 | 6 | SM00076 | |
| Domain | INTERFERON_A_B_D | 2.69e-10 | 17 | 102 | 6 | PS00252 | |
| Domain | Glyco_hydro_47 | 2.90e-08 | 7 | 102 | 4 | PF01532 | |
| Domain | - | 2.90e-08 | 7 | 102 | 4 | 1.50.10.50 | |
| Domain | Glyco_hydro_47 | 5.77e-08 | 8 | 102 | 4 | IPR001382 | |
| Domain | ORMDL | 1.58e-07 | 3 | 102 | 3 | PF04061 | |
| Domain | ORMDL | 1.58e-07 | 3 | 102 | 3 | IPR007203 | |
| Domain | - | 2.99e-07 | 50 | 102 | 6 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 3.38e-07 | 51 | 102 | 6 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 3.14e-06 | 74 | 102 | 6 | IPR009079 | |
| Domain | Plexin_cytopl | 1.30e-05 | 9 | 102 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.30e-05 | 9 | 102 | 3 | IPR013548 | |
| Domain | Plexin | 1.30e-05 | 9 | 102 | 3 | IPR031148 | |
| Domain | Pecanex_C | 1.76e-04 | 4 | 102 | 2 | PF05041 | |
| Domain | Pecanex | 1.76e-04 | 4 | 102 | 2 | IPR007735 | |
| Domain | FA58C | 1.96e-04 | 21 | 102 | 3 | SM00231 | |
| Domain | FA58C_3 | 1.96e-04 | 21 | 102 | 3 | PS50022 | |
| Domain | FA58C_1 | 1.96e-04 | 21 | 102 | 3 | PS01285 | |
| Domain | FA58C_2 | 1.96e-04 | 21 | 102 | 3 | PS01286 | |
| Domain | F5_F8_type_C | 2.94e-04 | 24 | 102 | 3 | PF00754 | |
| Domain | FA58C | 2.94e-04 | 24 | 102 | 3 | IPR000421 | |
| Domain | IPT | 4.21e-04 | 27 | 102 | 3 | SM00429 | |
| Domain | Clathrin | 6.09e-04 | 7 | 102 | 2 | PF00637 | |
| Domain | CHCR | 6.09e-04 | 7 | 102 | 2 | PS50236 | |
| Domain | TIG | 6.36e-04 | 31 | 102 | 3 | PF01833 | |
| Domain | Sema | 6.36e-04 | 31 | 102 | 3 | SM00630 | |
| Domain | Semap_dom | 6.36e-04 | 31 | 102 | 3 | IPR001627 | |
| Domain | Sema | 6.36e-04 | 31 | 102 | 3 | PF01403 | |
| Domain | SEMA | 6.36e-04 | 31 | 102 | 3 | PS51004 | |
| Domain | SNF2_N | 6.99e-04 | 32 | 102 | 3 | IPR000330 | |
| Domain | PSI | 6.99e-04 | 32 | 102 | 3 | PF01437 | |
| Domain | IPT | 6.99e-04 | 32 | 102 | 3 | IPR002909 | |
| Domain | FIBRINOGEN_C_1 | 6.99e-04 | 32 | 102 | 3 | PS00514 | |
| Domain | SNF2_N | 6.99e-04 | 32 | 102 | 3 | PF00176 | |
| Domain | Fibrinogen_a/b/g_C_dom | 6.99e-04 | 32 | 102 | 3 | IPR002181 | |
| Domain | Plexin_repeat | 6.99e-04 | 32 | 102 | 3 | IPR002165 | |
| Domain | FIBRINOGEN_C_2 | 6.99e-04 | 32 | 102 | 3 | PS51406 | |
| Domain | Clathrin_H-chain/VPS_repeat | 8.09e-04 | 8 | 102 | 2 | IPR000547 | |
| Domain | Cadherin_tail | 1.07e-03 | 37 | 102 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 1.07e-03 | 37 | 102 | 3 | IPR031904 | |
| Domain | LAM_G_DOMAIN | 1.16e-03 | 38 | 102 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.35e-03 | 40 | 102 | 3 | PF02210 | |
| Domain | PSI | 1.78e-03 | 44 | 102 | 3 | IPR016201 | |
| Domain | LamG | 1.78e-03 | 44 | 102 | 3 | SM00282 | |
| Domain | EGF_3 | 1.83e-03 | 235 | 102 | 6 | PS50026 | |
| Domain | PSI | 2.02e-03 | 46 | 102 | 3 | SM00423 | |
| Domain | EGF-like_dom | 2.45e-03 | 249 | 102 | 6 | IPR000742 | |
| Domain | EGF_1 | 2.76e-03 | 255 | 102 | 6 | PS00022 | |
| Domain | EGF_2 | 3.34e-03 | 265 | 102 | 6 | PS01186 | |
| Domain | Laminin_G | 3.92e-03 | 58 | 102 | 3 | IPR001791 | |
| Domain | HEAT | 3.92e-03 | 58 | 102 | 3 | IPR000357 | |
| Domain | - | 4.50e-03 | 122 | 102 | 4 | 3.40.30.10 | |
| Domain | EGF | 5.04e-03 | 126 | 102 | 4 | PF00008 | |
| Domain | Cadherin_2 | 5.41e-03 | 65 | 102 | 3 | PF08266 | |
| Domain | Cadherin_N | 5.41e-03 | 65 | 102 | 3 | IPR013164 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.52e-10 | 30 | 74 | 7 | M936 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 2.01e-10 | 17 | 74 | 6 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 3.01e-10 | 18 | 74 | 6 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 4.37e-10 | 19 | 74 | 6 | M47450 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 4.91e-10 | 35 | 74 | 7 | M48246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 6.22e-10 | 20 | 74 | 6 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 8.68e-10 | 21 | 74 | 6 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.19e-09 | 22 | 74 | 6 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.19e-09 | 22 | 74 | 6 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 1.60e-09 | 23 | 74 | 6 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.60e-09 | 23 | 74 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 2.13e-09 | 24 | 74 | 6 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.13e-09 | 24 | 74 | 6 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 2.13e-09 | 24 | 74 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.61e-09 | 26 | 74 | 6 | M982 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 4.00e-09 | 73 | 74 | 8 | M39837 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.13e-08 | 31 | 74 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.13e-08 | 31 | 74 | 6 | M47964 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.04e-08 | 34 | 74 | 6 | MM15631 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 2.45e-08 | 35 | 74 | 6 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 3.48e-08 | 37 | 74 | 6 | M39785 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 3.82e-08 | 19 | 74 | 5 | MM1571 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 8.36e-08 | 71 | 74 | 7 | M15913 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.28e-07 | 82 | 74 | 7 | M1002 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.86e-07 | 52 | 74 | 6 | M13103 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 3.11e-07 | 28 | 74 | 5 | MM1378 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 4.03e-07 | 55 | 74 | 6 | M11844 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 7.36e-07 | 33 | 74 | 5 | MM1379 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 7.77e-07 | 98 | 74 | 7 | M48247 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.10e-06 | 65 | 74 | 6 | M272 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 1.74e-06 | 39 | 74 | 5 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.25e-06 | 41 | 74 | 5 | MM1493 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.05e-06 | 120 | 74 | 7 | M48233 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 3.24e-06 | 78 | 74 | 6 | M973 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.22e-06 | 126 | 74 | 7 | M45009 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 6.14e-06 | 87 | 74 | 6 | MM15915 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 6.57e-06 | 88 | 74 | 6 | M16004 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 7.71e-06 | 138 | 74 | 7 | MM15635 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.54e-05 | 102 | 74 | 6 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.63e-05 | 103 | 74 | 6 | M39434 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 2.54e-05 | 299 | 74 | 9 | M41727 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 5.33e-05 | 127 | 74 | 6 | M42533 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 7.81e-05 | 136 | 74 | 6 | M42547 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 8.13e-05 | 137 | 74 | 6 | M5669 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 9.50e-05 | 204 | 74 | 7 | M45011 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.39e-04 | 151 | 74 | 6 | M39801 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.60e-04 | 155 | 74 | 6 | M17411 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 1.73e-04 | 21 | 74 | 3 | M27875 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.65e-04 | 170 | 74 | 6 | M941 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 3.31e-04 | 26 | 74 | 3 | M907 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 3.71e-04 | 27 | 74 | 3 | MM14646 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 5.63e-04 | 273 | 74 | 7 | M983 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 7.73e-04 | 471 | 74 | 9 | M39009 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 7.85e-04 | 472 | 74 | 9 | MM14539 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 8.05e-04 | 35 | 74 | 3 | M918 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 9.49e-04 | 37 | 74 | 3 | M554 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 9.56e-04 | 9 | 74 | 2 | MM15030 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.11e-03 | 39 | 74 | 3 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.19e-03 | 40 | 74 | 3 | M41816 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.45e-03 | 11 | 74 | 2 | MM14732 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO4 TRPC5 PSMD2 CP SLC4A3 SLC8A3 LCN15 SLC6A20 CLTC ABCD3 SLC5A8 | 1.50e-03 | 736 | 74 | 11 | M27287 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.58e-03 | 326 | 74 | 7 | MM15917 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.73e-03 | 12 | 74 | 2 | M15243 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.94e-03 | 249 | 74 | 6 | M5988 | |
| Pathway | BIOCARTA_ERAD_PATHWAY | 2.37e-03 | 14 | 74 | 2 | MM1539 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.37e-03 | 14 | 74 | 2 | MM15029 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 2.37e-03 | 14 | 74 | 2 | MM15047 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 2.37e-03 | 14 | 74 | 2 | M7578 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.41e-03 | 51 | 74 | 3 | MM14967 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.48e-03 | 108 | 74 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.57e-03 | 109 | 74 | 4 | MM15074 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 2.60e-03 | 264 | 74 | 6 | M9809 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.73e-03 | 15 | 74 | 2 | MM15031 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.84e-03 | 681 | 74 | 10 | MM14985 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.05e-03 | 575 | 74 | 9 | M29853 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 3.11e-03 | 16 | 74 | 2 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 3.11e-03 | 16 | 74 | 2 | M8245 | |
| Pubmed | 6.32e-13 | 12 | 106 | 6 | 16565497 | ||
| Pubmed | 6.32e-13 | 12 | 106 | 6 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 6.32e-13 | 12 | 106 | 6 | 8760352 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 6.32e-13 | 12 | 106 | 6 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 6.32e-13 | 12 | 106 | 6 | 1886773 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 6.32e-13 | 12 | 106 | 6 | 7530016 | |
| Pubmed | 6.32e-13 | 12 | 106 | 6 | 9794206 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 6.32e-13 | 12 | 106 | 6 | 7684767 | |
| Pubmed | 6.32e-13 | 12 | 106 | 6 | 17451966 | ||
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 6.32e-13 | 12 | 106 | 6 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 6.32e-13 | 12 | 106 | 6 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 6.32e-13 | 12 | 106 | 6 | 3758677 | |
| Pubmed | 6.32e-13 | 12 | 106 | 6 | 8245849 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 1.17e-12 | 13 | 106 | 6 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 1.17e-12 | 13 | 106 | 6 | 2014240 | |
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 18005734 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 12050368 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 1.17e-12 | 13 | 106 | 6 | 2987810 | |
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 1.17e-12 | 13 | 106 | 6 | 6094686 | |
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 19130550 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 1655578 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 2471809 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 22739040 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 8438572 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 9343822 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 9181467 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 1.17e-12 | 13 | 106 | 6 | 23255800 | |
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 7523540 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 1.17e-12 | 13 | 106 | 6 | 18726328 | |
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 19706714 | ||
| Pubmed | 1.17e-12 | 13 | 106 | 6 | 18572754 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 14983024 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 2.04e-12 | 14 | 106 | 6 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 2.04e-12 | 14 | 106 | 6 | 7526537 | |
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 19559726 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 25972534 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 15240719 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 7583919 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 16418394 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 18272764 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 2987811 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 11884139 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 19004943 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 21172865 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 2552026 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 2.04e-12 | 14 | 106 | 6 | 15254193 | |
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 2.04e-12 | 14 | 106 | 6 | 7532202 | |
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 16278001 | ||
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 2.04e-12 | 14 | 106 | 6 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 2.04e-12 | 14 | 106 | 6 | 17517919 | |
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 2.04e-12 | 14 | 106 | 6 | 1381203 | |
| Pubmed | 2.04e-12 | 14 | 106 | 6 | 8345204 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 3.40e-12 | 15 | 106 | 6 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 3.40e-12 | 15 | 106 | 6 | 18339807 | |
| Pubmed | 3.40e-12 | 15 | 106 | 6 | 8786318 | ||
| Pubmed | 3.40e-12 | 15 | 106 | 6 | 15684736 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 3.40e-12 | 15 | 106 | 6 | 8661419 | |
| Pubmed | 3.40e-12 | 15 | 106 | 6 | 9520456 | ||
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 5.42e-12 | 16 | 106 | 6 | 22315404 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 5.42e-12 | 16 | 106 | 6 | 18414664 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 5.42e-12 | 16 | 106 | 6 | 7904170 | |
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 8.36e-12 | 17 | 106 | 6 | 15233997 | |
| Pubmed | 8.36e-12 | 17 | 106 | 6 | 22814248 | ||
| Pubmed | 1.25e-11 | 18 | 106 | 6 | 1905933 | ||
| Pubmed | Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. | 1.25e-11 | 18 | 106 | 6 | 20096141 | |
| Pubmed | 1.82e-11 | 19 | 106 | 6 | 7511078 | ||
| Pubmed | 1.82e-11 | 19 | 106 | 6 | 7815507 | ||
| Pubmed | 1.82e-11 | 19 | 106 | 6 | 1385305 | ||
| Pubmed | 1.82e-11 | 19 | 106 | 6 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 1.82e-11 | 19 | 106 | 6 | 1708818 | |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 2.60e-11 | 20 | 106 | 6 | 11694501 | |
| Pubmed | 2.60e-11 | 20 | 106 | 6 | 8764000 | ||
| Pubmed | 3.63e-11 | 21 | 106 | 6 | 9108403 | ||
| Pubmed | 4.98e-11 | 22 | 106 | 6 | 7913356 | ||
| Pubmed | 4.98e-11 | 22 | 106 | 6 | 23100517 | ||
| Pubmed | 4.98e-11 | 22 | 106 | 6 | 16160188 | ||
| Pubmed | 6.72e-11 | 23 | 106 | 6 | 9225992 | ||
| Pubmed | PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response. | 8.94e-11 | 24 | 106 | 6 | 35037428 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.09e-10 | 11 | 106 | 5 | 8389790 | |
| Pubmed | 1.09e-10 | 11 | 106 | 5 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.09e-10 | 11 | 106 | 5 | 6444699 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.09e-10 | 11 | 106 | 5 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.09e-10 | 11 | 106 | 5 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.09e-10 | 11 | 106 | 5 | 15795237 | |
| Pubmed | 1.09e-10 | 11 | 106 | 5 | 9794439 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.09e-10 | 11 | 106 | 5 | 10448195 | |
| Pubmed | 1.09e-10 | 11 | 106 | 5 | 25310498 | ||
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.09e-10 | 11 | 106 | 5 | 19120292 | |
| Pubmed | 1.17e-10 | 25 | 106 | 6 | 27183626 | ||
| Pubmed | Modulation of HIV-1 transcription by cytokines and chemokines. | 1.17e-10 | 25 | 106 | 6 | 16375755 | |
| Pubmed | Role of HIV-1 Vpu protein for virus spread and pathogenesis. | 1.17e-10 | 25 | 106 | 6 | 18672082 | |
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 1.52e-10 | 26 | 106 | 6 | 38744293 | |
| Pubmed | 1.52e-10 | 26 | 106 | 6 | 9658081 | ||
| Pubmed | 1.86e-10 | 12 | 106 | 5 | 22685550 | ||
| Pubmed | 1.86e-10 | 12 | 106 | 5 | 3017340 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.86e-10 | 12 | 106 | 5 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.86e-10 | 12 | 106 | 5 | 33123150 | |
| Pubmed | 1.86e-10 | 12 | 106 | 5 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 1.86e-10 | 12 | 106 | 5 | 8304945 | |
| Interaction | FIBIN interactions | 7.54e-08 | 71 | 103 | 7 | int:FIBIN | |
| Interaction | IFNA13 interactions | 2.07e-07 | 11 | 103 | 4 | int:IFNA13 | |
| Interaction | IFNA1 interactions | 1.12e-06 | 16 | 103 | 4 | int:IFNA1 | |
| Interaction | CEACAM8 interactions | 2.60e-06 | 119 | 103 | 7 | int:CEACAM8 | |
| Interaction | IFNA5 interactions | 4.39e-06 | 22 | 103 | 4 | int:IFNA5 | |
| Interaction | SEMA6D interactions | 5.29e-06 | 23 | 103 | 4 | int:SEMA6D | |
| Interaction | IFNA6 interactions | 7.13e-06 | 8 | 103 | 3 | int:IFNA6 | |
| Interaction | RLN1 interactions | 8.19e-06 | 93 | 103 | 6 | int:RLN1 | |
| Interaction | CLEC2B interactions | 1.05e-05 | 147 | 103 | 7 | int:CLEC2B | |
| Interaction | BTNL2 interactions | 1.48e-05 | 155 | 103 | 7 | int:BTNL2 | |
| Interaction | WDPCP interactions | 2.59e-05 | 2 | 103 | 2 | int:WDPCP | |
| Interaction | CFC1 interactions | 4.62e-05 | 126 | 103 | 6 | int:CFC1 | |
| Interaction | CBLN4 interactions | 4.83e-05 | 127 | 103 | 6 | int:CBLN4 | |
| Interaction | IFNA4 interactions | 5.63e-05 | 41 | 103 | 4 | int:IFNA4 | |
| Interaction | GPIHBP1 interactions | 6.25e-05 | 133 | 103 | 6 | int:GPIHBP1 | |
| Interaction | SCGB1D1 interactions | 6.25e-05 | 133 | 103 | 6 | int:SCGB1D1 | |
| Interaction | ARRDC5 interactions | 6.81e-05 | 43 | 103 | 4 | int:ARRDC5 | |
| Interaction | IFNA14 interactions | 6.92e-05 | 16 | 103 | 3 | int:IFNA14 | |
| Interaction | ISLR interactions | 7.67e-05 | 138 | 103 | 6 | int:ISLR | |
| Interaction | DNAJB9 interactions | 8.05e-05 | 202 | 103 | 7 | int:DNAJB9 | |
| Interaction | SHH interactions | 1.00e-04 | 18 | 103 | 3 | int:SHH | |
| Interaction | SUSD4 interactions | 1.24e-04 | 50 | 103 | 4 | int:SUSD4 | |
| Interaction | KLK15 interactions | 1.26e-04 | 151 | 103 | 6 | int:KLK15 | |
| Interaction | PCDHA10 interactions | 1.86e-04 | 22 | 103 | 3 | int:PCDHA10 | |
| Cytoband | 9p22 | 2.24e-11 | 25 | 106 | 6 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 4.70e-07 | 124 | 106 | 6 | chr9p21 | |
| Cytoband | 6q22.31 | 1.79e-03 | 27 | 106 | 2 | 6q22.31 | |
| Cytoband | 5q31 | 2.45e-03 | 115 | 106 | 3 | 5q31 | |
| Cytoband | 16q23.1 | 2.50e-03 | 32 | 106 | 2 | 16q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q23 | 2.51e-03 | 116 | 106 | 3 | chr16q23 | |
| Cytoband | 17q23.2 | 2.66e-03 | 33 | 106 | 2 | 17q23.2 | |
| Cytoband | 12q23.1 | 2.66e-03 | 33 | 106 | 2 | 12q23.1 | |
| GeneFamily | Interferons | 1.07e-09 | 32 | 62 | 6 | 598 | |
| GeneFamily | Plexins | 3.18e-06 | 9 | 62 | 3 | 683 | |
| GeneFamily | Clustered protocadherins | 1.38e-03 | 64 | 62 | 3 | 20 | |
| GeneFamily | Fibronectin type III domain containing | 2.21e-03 | 160 | 62 | 4 | 555 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.33e-03 | 21 | 62 | 2 | 813 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 1.08e-07 | 29 | 106 | 5 | MM586 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 1.92e-07 | 210 | 106 | 9 | MM751 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 5.08e-07 | 39 | 106 | 5 | M41095 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 8.94e-07 | 80 | 106 | 6 | MM646 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 1.28e-06 | 85 | 106 | 6 | MM684 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_2D_DN | 5.74e-06 | 63 | 106 | 5 | M7615 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.57e-05 | 131 | 106 | 6 | MM1127 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 1.86e-05 | 80 | 106 | 5 | MM1229 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | CACNA2D1 TM9SF4 IFNA4 IFNA5 IFNA6 IFNA8 IFNA17 IFNA21 VANGL1 TTLL4 EDEM1 | 2.51e-05 | 584 | 106 | 11 | MM1080 |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.79e-05 | 87 | 106 | 5 | MM652 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.47e-07 | 166 | 106 | 7 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.89e-06 | 193 | 106 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 8.44e-06 | 200 | 106 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.70e-05 | 157 | 106 | 5 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 163 | 106 | 5 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 163 | 106 | 5 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 165 | 106 | 5 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 165 | 106 | 5 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 166 | 106 | 5 | 35db3022c33d6f8bb6587d9eec89a7cccb70271a | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-05 | 170 | 106 | 5 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-05 | 173 | 106 | 5 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-05 | 173 | 106 | 5 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 181 | 106 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.27e-05 | 181 | 106 | 5 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.66e-05 | 183 | 106 | 5 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.27e-05 | 186 | 106 | 5 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.27e-05 | 186 | 106 | 5 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.27e-05 | 186 | 106 | 5 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | SMG-Goblet|World / shred by cell class for bronchial biopsy | 8.48e-05 | 187 | 106 | 5 | 5178118bdec91495253c88f58fd908cf831de7ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.70e-05 | 188 | 106 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.92e-05 | 189 | 106 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.14e-05 | 190 | 106 | 5 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.14e-05 | 190 | 106 | 5 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.60e-05 | 192 | 106 | 5 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.84e-05 | 193 | 106 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 194 | 106 | 5 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.03e-04 | 195 | 106 | 5 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 1.03e-04 | 195 | 106 | 5 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | Severe-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-04 | 196 | 106 | 5 | ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 196 | 106 | 5 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-04 | 196 | 106 | 5 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-04 | 197 | 106 | 5 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 198 | 106 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 198 | 106 | 5 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 198 | 106 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| Drug | Hiltonol | 6.26e-08 | 23 | 106 | 5 | CID000431963 | |
| Drug | gunacin | 4.29e-07 | 14 | 106 | 4 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 5.82e-07 | 15 | 106 | 4 | CID000125229 | |
| Drug | podophyllin | 1.29e-06 | 18 | 106 | 4 | CID011979494 | |
| Drug | Nyco | 1.29e-06 | 18 | 106 | 4 | CID000071618 | |
| Drug | Sesquimustard | 1.66e-06 | 43 | 106 | 5 | CID000019092 | |
| Drug | DTIC | 2.16e-06 | 81 | 106 | 6 | CID005281007 | |
| Drug | formosanin C | 3.04e-06 | 22 | 106 | 4 | CID000073597 | |
| Drug | Yfrkd | 3.39e-06 | 7 | 106 | 3 | CID000129984 | |
| Drug | cycloferon | 4.39e-06 | 24 | 106 | 4 | CID000038072 | |
| Drug | hycanthone | 5.21e-06 | 25 | 106 | 4 | CID000003634 | |
| Drug | Chebi:36708 | 5.40e-06 | 8 | 106 | 3 | CID011966289 | |
| Drug | 1hiv | 5.40e-06 | 8 | 106 | 3 | CID005479205 | |
| Drug | ABMP | 6.13e-06 | 26 | 106 | 4 | CID000080567 | |
| Drug | inosiplex | 7.17e-06 | 27 | 106 | 4 | CID000037510 | |
| Drug | AC1L1U53 | 8.86e-06 | 60 | 106 | 5 | CID000060907 | |
| Drug | poly rI:rC | 1.11e-05 | 30 | 106 | 4 | CID011979660 | |
| Drug | pipobroman | 1.15e-05 | 10 | 106 | 3 | CID000004842 | |
| Drug | CHEMBL466993 | 1.44e-05 | 32 | 106 | 4 | CID005320808 | |
| Drug | flesinoxan | 1.58e-05 | 11 | 106 | 3 | CID000057347 | |
| Drug | carprofen | 1.85e-05 | 34 | 106 | 4 | CID000002581 | |
| Drug | oxymatrine | 1.85e-05 | 34 | 106 | 4 | CID000114850 | |
| Drug | N6-methyl-(R)-roscovitine | 2.03e-05 | 71 | 106 | 5 | CID005289296 | |
| Drug | tilorone | 2.08e-05 | 35 | 106 | 4 | CID000005475 | |
| Drug | pyran | 2.60e-05 | 37 | 106 | 4 | CID000033703 | |
| Drug | R 842 | 2.71e-05 | 13 | 106 | 3 | CID000130714 | |
| Drug | AC1O52EF | 2.71e-05 | 13 | 106 | 3 | CID006450817 | |
| Drug | anagrelide | 2.90e-05 | 38 | 106 | 4 | CID000002182 | |
| Drug | isofagomine lactam | 3.22e-05 | 39 | 106 | 4 | CID000448980 | |
| Drug | Lanicemine | 3.44e-05 | 14 | 106 | 3 | CID003038485 | |
| Drug | AC1L9FQV | 4.08e-05 | 82 | 106 | 5 | CID000444118 | |
| Drug | 1 ind | 4.34e-05 | 42 | 106 | 4 | CID003037877 | |
| Drug | AC1L9AL3 | 6.23e-05 | 46 | 106 | 4 | CID000441122 | |
| Drug | YNK01 | 6.36e-05 | 17 | 106 | 3 | CID000084071 | |
| Drug | entecavir | 6.79e-05 | 47 | 106 | 4 | CID000153941 | |
| Drug | p203 | 7.61e-05 | 18 | 106 | 3 | CID000019228 | |
| Drug | isosorbide-5-mononitrate | 7.61e-05 | 18 | 106 | 3 | CID000027661 | |
| Drug | NMMA | 7.86e-05 | 94 | 106 | 5 | CID000170607 | |
| Drug | adefovir dipivoxil | 8.00e-05 | 49 | 106 | 4 | CID000060871 | |
| Drug | amantadine | 8.26e-05 | 95 | 106 | 5 | CID000002130 | |
| Drug | trifluorothymidine | 9.37e-05 | 51 | 106 | 4 | CID000006256 | |
| Drug | famciclovir | 1.01e-04 | 52 | 106 | 4 | CID000003324 | |
| Drug | bropirimine | 1.01e-04 | 52 | 106 | 4 | CID000065457 | |
| Drug | Ciluprevir [USAN] | 1.06e-04 | 20 | 106 | 3 | CID006450803 | |
| Drug | val-mCyd | 1.06e-04 | 20 | 106 | 3 | CID006918726 | |
| Drug | Ampligen | 1.09e-04 | 53 | 106 | 4 | CID000038077 | |
| Drug | dipyridamole | 1.12e-04 | 162 | 106 | 6 | CID000003108 | |
| Drug | L DO | 1.23e-04 | 21 | 106 | 3 | CID000097725 | |
| Drug | m IU | 1.35e-04 | 56 | 106 | 4 | CID006852123 | |
| Drug | AC1L1J7E | 1.51e-04 | 171 | 106 | 6 | CID000004900 | |
| Drug | Lps2 | 1.55e-04 | 58 | 106 | 4 | CID000454710 | |
| Drug | C12063 | 1.80e-04 | 429 | 106 | 9 | CID005282055 | |
| Drug | AC1L1ZCT | 1.85e-04 | 24 | 106 | 3 | CID000038235 | |
| Drug | cimetidine | 1.93e-04 | 179 | 106 | 6 | CID000002756 | |
| Drug | LB80380 | 2.09e-04 | 25 | 106 | 3 | CID006480442 | |
| Drug | DB08594 | 2.13e-04 | 5 | 106 | 2 | CID005289428 | |
| Drug | Km 201 | 2.13e-04 | 5 | 106 | 2 | CID000089125 | |
| Drug | adefovir | 2.27e-04 | 64 | 106 | 4 | CID000060172 | |
| Drug | AC1L1HZP | 2.27e-04 | 64 | 106 | 4 | CID000004361 | |
| Drug | medrol | 2.38e-04 | 186 | 106 | 6 | CID000004159 | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.52e-04 | 188 | 106 | 6 | 7466_UP | |
| Drug | AC1O51IP | 2.56e-04 | 66 | 106 | 4 | CID006450363 | |
| Drug | copolymer 1 | 2.56e-04 | 66 | 106 | 4 | CID003081884 | |
| Drug | vinblastine | 2.59e-04 | 189 | 106 | 6 | CID000013342 | |
| Drug | VX-497 | 2.64e-04 | 27 | 106 | 3 | CID000153241 | |
| Drug | acyclovir | 2.89e-04 | 124 | 106 | 5 | CID000002022 | |
| Drug | AC1NRD2B | 2.95e-04 | 28 | 106 | 3 | CID005289317 | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 1480_DN | |
| Drug | cycloleucine | 3.04e-04 | 69 | 106 | 4 | CID000002901 | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 3695_DN | |
| Drug | methimazole | 3.11e-04 | 126 | 106 | 5 | CID001349907 | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 6780_DN | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; HL60; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 2451_UP | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 7328_UP | |
| Drug | NSC141633 | 3.28e-04 | 29 | 106 | 3 | CID000003628 | |
| Drug | NM 108 | 3.28e-04 | 29 | 106 | 3 | CID000500901 | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 2732_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 3402_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 6323_UP | |
| Drug | 9-cis-acitretin | 3.39e-04 | 71 | 106 | 4 | CID000041317 | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.42e-04 | 199 | 106 | 6 | 5872_UP | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.42e-04 | 199 | 106 | 6 | 7191_DN | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.28e-06 | 8 | 103 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 3.11e-06 | 29 | 103 | 4 | EFO_0008009 | |
| Disease | triglyceride change measurement, low density lipoprotein cholesterol measurement | 1.21e-05 | 2 | 103 | 2 | EFO_0004611, EFO_0007681 | |
| Disease | neuroticism measurement, cognitive function measurement | TRHDE PCDHA9 PSEN2 MYO6 PCDHA13 PCDHA12 WDPCP DENND1B PPP6C HECTD2 | 2.98e-05 | 566 | 103 | 10 | EFO_0007660, EFO_0008354 |
| Disease | Hypoplastic Left Heart Syndrome | 1.20e-04 | 5 | 103 | 2 | C0152101 | |
| Disease | blood barium measurement | 2.28e-04 | 34 | 103 | 3 | EFO_0021528 | |
| Disease | asthma (implicated_via_orthology) | 2.49e-04 | 35 | 103 | 3 | DOID:2841 (implicated_via_orthology) | |
| Disease | Shortened QT interval | 6.50e-04 | 11 | 103 | 2 | C0151879 | |
| Disease | neutrophil count, basophil count | 1.15e-03 | 224 | 103 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | Tremor, Rubral | 1.40e-03 | 16 | 103 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.40e-03 | 16 | 103 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.40e-03 | 16 | 103 | 2 | C0278161 | |
| Disease | Abnormal coordination | 1.40e-03 | 16 | 103 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.40e-03 | 16 | 103 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 1.40e-03 | 16 | 103 | 2 | C0240991 | |
| Disease | Dementia | 1.59e-03 | 17 | 103 | 2 | C0497327 | |
| Disease | age-related macular degeneration, COVID-19 | 1.83e-03 | 69 | 103 | 3 | EFO_0001365, MONDO_0100096 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-03 | 152 | 103 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant tumor of colon | 2.37e-03 | 159 | 103 | 4 | C0007102 | |
| Disease | triacylglycerol 54:8 measurement | 2.91e-03 | 23 | 103 | 2 | EFO_0010426 | |
| Disease | wellbeing measurement | 2.96e-03 | 692 | 103 | 8 | EFO_0007869 | |
| Disease | susceptibility to childhood ear infection measurement | 3.08e-03 | 171 | 103 | 4 | EFO_0007904 | |
| Disease | Ataxia | 3.44e-03 | 25 | 103 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALVVLENYYKDFTIY | 276 | Q8TAA9 | |
| LIEFYEDYFKVPYSL | 376 | Q9UKU6 | |
| ISLIFIYETFYKLYK | 831 | P48751 | |
| IIYSTKLYRFFKYIE | 336 | Q9BSF8 | |
| LYVSSFYEEYLSVIL | 1056 | Q9BZ76 | |
| EIYTSLAKYLESYFL | 251 | Q96NH3 | |
| YVELYLVADYLEFQK | 211 | Q9H013 | |
| LFVSSFYKEYLSVII | 1056 | Q9C0A0 | |
| IYRLVADYTLEKKIY | 861 | Q9Y4B4 | |
| ITSDFIPRLVYAYKY | 791 | Q32M45 | |
| EFIKSIFYSVLIISY | 396 | Q9Y620 | |
| KLVSTYKNYYSLVLD | 396 | Q9Y5H5 | |
| DVLYYIFLCIQKYLF | 546 | Q2TAL8 | |
| YKYSRVADYIVKVSL | 256 | Q96EP9 | |
| LYKKALYLQYTDETF | 66 | P00450 | |
| PIVLYLLASFYTKYD | 106 | Q53FV1 | |
| ILYSSKLYRFFKYIE | 286 | Q7Z5Y7 | |
| EYAGYLLYSERTILK | 2196 | Q07954 | |
| GIDSYYEYLLKAYVL | 291 | Q9BZQ6 | |
| YVQLYTDFLLNKSIY | 616 | Q5U5R9 | |
| EIIRYIFAYLDIQYE | 16 | O60760 | |
| YFQRITLYLTEKKYS | 146 | P01568 | |
| KIYYLLLEEIYDYQV | 5056 | Q5CZC0 | |
| LNYQEFKLYTIIYTD | 156 | A8MZ26 | |
| ESFFLAETVKYLYLL | 426 | Q9BV94 | |
| RKILITYYVKSIIYY | 1481 | Q9H6A9 | |
| LYQLGILKDYYTAAL | 61 | Q63HM2 | |
| YSYITKYKDEILAAL | 1856 | Q9UIW2 | |
| YFYVTKYRQEILTAL | 1831 | P51805 | |
| LTEIYKYIVKYFDEI | 1521 | O60486 | |
| KFIFYELLTRYDLIS | 186 | Q14123 | |
| YFLTRVYSEYLEDVL | 111 | Q9H1Q7 | |
| YFQRITLYLTEKKYS | 146 | P01569 | |
| TAQLLVLYYILSYEE | 646 | Q9H0H0 | |
| VLYYILSYEEALLAN | 651 | Q9H0H0 | |
| YKKIVLDLLVYGLYD | 86 | Q9BYG7 | |
| YSSFAVLYIYKELEG | 116 | Q6UWW0 | |
| PIILYFLASFYTKYD | 106 | Q9P0S3 | |
| VVAAELIYFLFLLYY | 2186 | Q7Z442 | |
| SIYFDNLEKYTDYIL | 1151 | Q9UMZ3 | |
| QYKFVYEVALEYLSS | 1426 | O14522 | |
| KLVSTYKNYYSLVLD | 396 | Q9Y5I0 | |
| YLIALYTKDEYFAVA | 111 | Q9Y4H2 | |
| RLEKLSALDYKIFYY | 201 | O95876 | |
| LSLLYLYLFDYTDTF | 281 | Q9NZS9 | |
| SISYDKILEETLYVY | 281 | O15228 | |
| YSFYYIKAKLEETIT | 626 | P54289 | |
| VYEVYKIYIFSLFLG | 291 | Q7Z388 | |
| SFYEYLLKSYILFGE | 371 | Q92611 | |
| FLAETLKYLYLIFSD | 606 | P33908 | |
| YFQRITLYLTEKKYS | 146 | P32881 | |
| VYYKLLNTLADYLAK | 106 | Q6P3S1 | |
| YLAKSLAEKLYLFQY | 16 | Q9NVU0 | |
| SYATVYLIYLKFKAT | 71 | P33947 | |
| FLESLEFYYPELYKL | 91 | Q9BXL7 | |
| YFQRITLYLTEKKYS | 146 | P01571 | |
| LYVSSFYEEYLSVIL | 1056 | Q96NU0 | |
| YYIVVYFPEKDITIL | 1041 | Q3ZCN5 | |
| PIVLYFLTSFYTKYD | 106 | Q8N138 | |
| KLVSTYKNYYSLVLD | 396 | Q9UN75 | |
| YLEDKVYLTGYNFTL | 101 | O43324 | |
| YFQRITLYLTEKKYS | 146 | P05013 | |
| LYKYFYAISNIEVIG | 271 | Q96CW9 | |
| LQYLYLEYNLIKEIS | 451 | Q8IW52 | |
| LYLESKLYELYLQLL | 931 | O75691 | |
| YAKTLYLLYAQLEEE | 591 | Q9HCS7 | |
| LTLEEYYSLLDVFYN | 336 | Q8N3R3 | |
| YTYLLLLLKSVVYFA | 156 | P03986 | |
| RYYPSFIVSDLYEKL | 386 | Q9H3E2 | |
| LTQIDKYLYSSEDYI | 426 | Q13200 | |
| ILSIYKYVSSIYRYD | 461 | Q149N8 | |
| VFYKLGITSTYEYLE | 106 | Q8N695 | |
| LEFDEETLYYVKVYL | 1226 | Q8TE82 | |
| YFQRITLYLTEKKYS | 146 | P05014 | |
| FVFYLSDYILTGTLK | 521 | Q9NP91 | |
| YLLSLVAIVLFFVYY | 206 | Q9NRX5 | |
| VRLTKYLYEEYLQAF | 156 | P28288 | |
| LYIAVIFYYKDNILV | 441 | Q8N957 | |
| VELYYRAIQFYLEFK | 1401 | Q00610 | |
| VYSKKVEYLYSLVYQ | 66 | Q6IBW4 | |
| VEYLYSLVYQALDFI | 71 | Q6IBW4 | |
| LLTYCEDVYLYYKLA | 2401 | Q96JI7 | |
| KYIDAASELIVYTYF | 166 | Q96JJ7 | |
| DEYVETLSKIYLSYY | 286 | Q8N1B4 | |
| YDLYEKTLKYNSDLL | 106 | Q6P2D0 | |
| TRSDLYEYIVDFLTY | 521 | Q8WUH2 | |
| EYLSGELYKDLILYS | 511 | Q9P2K2 | |
| LLLLYCKYEYFDLAA | 326 | Q8N4P2 | |
| YVLVYAIFYFVNKLD | 581 | Q92544 | |
| GYYSLETFTYLLALK | 86 | O00743 | |
| TYLYSVEIKLAKIGY | 156 | C9JQI7 | |
| ELLEYYIKVILDYNT | 451 | Q14258 | |
| FLFTYIYLGEVLKTY | 181 | P49810 | |
| ILEYADKVFTYIFIL | 1231 | Q9UQD0 | |
| YLAYILYFVLKEFCI | 126 | Q8N0U8 | |
| AAEAALEKYYLSIFY | 16 | Q9BXA5 | |
| LEKYYLSIFYGIEFV | 21 | Q9BXA5 | |
| YLAYILDTLVFAFSK | 526 | Q92973 | |
| TFYILVKAIYTLGYS | 121 | P41587 | |
| YLASYLTNKYVLSVL | 16 | Q24JQ0 | |
| LLLLYCKYEYFDLAA | 326 | Q86WT1 | |
| LYVEDTFVYYIKTLF | 3531 | Q7Z7G8 | |
| TFVYYIKTLFDTYLP | 3536 | Q7Z7G8 | |
| AVYYLAEYNLEFLKT | 636 | Q6UXY8 | |
| YLATISLKIVAYVKY | 446 | Q9UL62 | |
| KYFISTYIDFVPYIA | 2176 | Q9BXT5 | |
| YLISGSKFDLRIYVY | 756 | Q14679 | |
| DLSYFIVSILYLKYE | 26 | Q9H6F2 | |
| ISDVLSDITYYVYKA | 441 | Q562E7 | |
| LYILFATLEAYCYIK | 911 | P57103 | |
| YSKDRIYTYVANILI | 81 | Q9UM54 | |
| QLYSFVTYYVEDLKV | 1476 | P52179 |